HomeAllergan

  • Botox shows efficacy in Multiple Sclerosis urinary symptoms

    • August 10, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Prophylactic Migraine drug Atogepant displays positive efficacy and safety results in Ph 2b/3 trials

    • June 13, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Allergan acquires depression compound from Aptinyx

    • May 24, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Allergan’s Ubrogepant registers second Positive Ph 3 Trial results in Migraine

    • April 28, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more